Related Experiment Videos
Cervical cancer as an AIDS-defining illness
M Maiman1, R G Fruchter, M Clark
1Department of Obstetrics and Gynecology, State University of New York-Health Science Center at Brooklyn, USA.
Obstetrics and Gynecology
|January 1, 1997
Summary
Cervical cancer is a significant AIDS-defining illness and the most common malignancy in HIV-infected women, especially in high-risk urban populations. Early diagnosis is crucial for managing this aggressive disease.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- Human immunodeficiency virus (HIV) infection is associated with various opportunistic infections and malignancies.
- Cervical cancer is a known complication in HIV-positive women, but its prevalence and impact relative to other AIDS-related cancers require ongoing evaluation.
Purpose of the Study:
- To determine the significance of cervical cancer within the spectrum of HIV-related diseases.
- To compare the characteristics of cervical cancer with other acquired immunodeficiency syndrome (AIDS)-related malignancies in HIV-infected women.
Main Methods:
- Retrospective review of data on cervical cancer and AIDS in women from New York City registries (1987-1995).
- Analysis of disease characteristics, HIV diagnosis timing, immunosuppression levels (CD4 counts), recurrence rates, and mortality in HIV-infected women with cervical cancer versus other AIDS-related malignancies.
Main Results:
- Cervical cancer was diagnosed in 28 HIV-positive women, serving as the initial AIDS-defining illness in 26 (4% of subjects).
- It was the most common AIDS-related malignancy (55%), followed by lymphoma (29%) and Kaposi sarcoma (16%).
- Women with cervical cancer had a higher recurrence rate (88%) and cancer was the cause of death in 95% of cases, despite similar survival intervals compared to other malignancies.
Conclusions:
- Cervical cancer is a critical AIDS-defining illness in urban, high-risk populations.
- It represents a significant proportion of AIDS-related malignancies among HIV-infected women.